NCT01023841

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 71 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: 5 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily application to the upper eyelid margins compared with vehicle in treating eyelash loss or hypotrichosis (inadequate or not enough eyelashes) in children.

Conditions

• Eyelash Hypotrichosis
• Alopecia Areata

Interventions

Type	Name	Description
DRUG	bimatoprost ophthalmic solution 0.03%	One drop applied to a sterile single-use-per-eye applicator and applied to upper eyelid margin (where the eyelashes meet the skin) once nightly for 4 months.
DRUG	Vehicle Sterile Solution	One drop applied to a sterile single-use-per-eye applicator and applied to upper eyelid margin (where the eyelashes meet the skin) once nightly for 4 months.

Timeline

• Start date: 2010-06-01
• Primary completion: 2012-11-02
• Completion: 2012-11-30
• First posted: 2009-12-02
• Last updated: 2019-04-17
• Results posted: 2013-09-13

Locations

2 sites across 2 countries: United States, Brazil